AAAAAA

   
Results: 1-25 | 26-40
Results: 1-25/40

Authors: TOSQUELLAS G BOLOGNA JC MORVAN F RAYNER B IMBACH JL
Citation: G. Tosquellas et al., FIRST SYNTHESIS OF ALTERNATING SATE-PHOSPHOTRIESTER PHOSPHODIESTER PROOLIGONUCLEOTIDES ON SOLID SUPPORT/, Bioorganic & medicinal chemistry letters, 8(20), 1998, pp. 2913-2918

Authors: MORVAN F IMBACH JL RAYNER B
Citation: F. Morvan et al., COMPARATIVE STABILITY OF TRIPLE HELICES CONTAINING MODIFIED DNA OR RNA PYRIMIDINE STRANDS, Nucleosides & nucleotides, 17(9-11), 1998, pp. 1949-1952

Authors: TOSQUELLAS G ALVAREZ K DELLAQUILA C MORVAN F VASSEUR JJ IMBACH JL RAYNER B
Citation: G. Tosquellas et al., THE PRO-OLIGONUCLEOTIDE APPROACH - SOLID-PHASE SYNTHESIS AND PRELIMINARY EVALUATION OF MODEL PRO-DODECATHYMIDYLATES, Nucleic acids research, 26(9), 1998, pp. 2069-2074

Authors: MORVAN F ZEIDLER J RAYNER B
Citation: F. Morvan et al., ALPHA-OLIGODEOXYNUCLEOTIDES CONTAINING 5-PROPYNYL ANALOGS OF ALPHA-DEOXYURIDINE AND ALPHA-DEOXYCYTIDINE - SYNTHESIS AND BASE-PAIRING PROPERTIES, Tetrahedron, 54(1-2), 1998, pp. 71-82

Authors: MIGNET N TOSQUELLAS G BARBER I MORVAN F RAYNER B IMBACH JL
Citation: N. Mignet et al., THE PROOLIGONUCLEOTIDE APPROACH - SYNTHESIS AND STABILITY OF CHIMERICPROOLIGONUCLEOTIDES IN CULTURE-MEDIUM AND IN TOTAL CELL EXTRACT, New journal of chemistry, 21(1), 1997, pp. 73-79

Authors: MORVAN F IMBACH JL RAYNER B
Citation: F. Morvan et al., COMPARATIVE STABILITY OF 8 DIFFERENT TRIPLE HELICES FORMED BY DIFFERENTLY MODIFIED DNA OR RNA PYRIMIDINE STRANDS AND A DNA HAIRPIN, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(4), 1997, pp. 327-334

Authors: MIGNET N MORVAN F RAYNER B IMBACH JL
Citation: N. Mignet et al., THE PRO-OLIGONUCLEOTIDE APPROACH .5. INFLUENCE OF THE PHOSPHORUS ATOMENVIRONMENT ON THE HYDROLYSIS OF ENZYMOLABILE DINUCLEOSIDE PHOSPHOTRIESTERS, Bioorganic & medicinal chemistry letters, 7(7), 1997, pp. 851-854

Authors: TOSQUELLAS G MORVAN F RAYNER B IMBACH JL
Citation: G. Tosquellas et al., THE PROOLIGONUCLEOTIDE APPROACH .4. SYNTHESIS OF CHIMERIC PROOLIGONUCLEOTIDES WITH 6 ENZYMOLABILE MASKING GROUPS AND UNEXPECTED DESULFURIZATION SIDE REACTION, Bioorganic & medicinal chemistry letters, 7(3), 1997, pp. 263-268

Authors: MIGNOT L UNTEREINER M RIVIERE A DOUILLARD JY MARTI P MORVAN F MARTY M
Citation: L. Mignot et al., INTRAVENOUS (IV) ITASETRON HYDROCHLORIDE (DAU 6215CI) - AN EFFECTIVE ALTERNATIVE TO ONDANSETRON (OND), European journal of cancer, 33, 1997, pp. 233-233

Authors: ESPIE M MIGNOT L LELEU F DEROQUANCOURT A MAYLIN C MORVAN F CLOT P MARTY M
Citation: M. Espie et al., ADJUVANT CMF IMPROVES OUTCOME OF NODE-NEGATIVE BREAST-CANCER (BC) IN PREMENOPAUSAL WOMEN - IN YEARS RESULTS OF A RANDOMIZED STUDY, European journal of cancer, 33, 1997, pp. 349-349

Authors: ANDRE T BENSMAINE MA LOUVET C LUCAS V BEERBLOCK K DESSEIGNE F FRANCOIS E MERROUCHE Y BOUCHE O MORVAN F CAROLA E DEGRAMONT A
Citation: T. Andre et al., ADDITION OF OXALIPLATIN (ELOXATINE(R), LOHP) TO THE SAME LEUCOVORIN (LV) AND 5-FLUOROURACIL (5FU) BIMONTHLY REGIMENS AFTER PROGRESSION IN PATIENTS (PTS) WITH METASTATIC COLORECTAL-CANCER (MCRC) - PRELIMINARY-REPORT, European journal of cancer, 33, 1997, pp. 738-738

Authors: ROUGIER P PAILLOT B LAPLANCHE A MORVAN F SEITZ JF REKACEWICZ C LAPLAIGE P JACOB J GRANDJOUAN S TIGAUD JM FABRI MC LUBOINSKI M DUCREUX M
Citation: P. Rougier et al., 5-FLUOROURACIL (5-FU) CONTINUOUS INTRAVENOUS-INFUSION COMPARED WITH BOLUS ADMINISTRATION - FINAL RESULTS OF A RANDOMIZED TRIAL IN METASTATIC COLORECTAL-CANCER, European journal of cancer, 33(11), 1997, pp. 1789-1793

Authors: MORVAN F TOSQUELLAS G MIGNET N BARBER I RAYNER B IMBACH JL
Citation: F. Morvan et al., THE PRO-OLIGONUCLEOTIDE APPROACH - CHIMERIC DODECAMERS BEARING 6 BIOREVERSIBLE PROTECTING GROUPS, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1213-1214

Authors: GANEM G DUBRAY B RAOUL Y COLIN P BARDET E DOUILLARD JY GOUDIER MJ HENNEQUIN C WALTER S MICHELLANGLET P MARTIN P MARON D MORVAN F ANDOLENKO P EXTRA JM
Citation: G. Ganem et al., CONCOMITANT CHEMORADIOTHERAPY FOLLOWED, WHERE FEASIBLE, BY SURGERY FOR CANCER OF THE ESOPHAGUS, Journal of clinical oncology, 15(2), 1997, pp. 701-711

Authors: DEGRAMONT A BASSET JF MILAN C ROUGIER P BOUCHE O ETIENNE PL MORVAN F LOUVET C GUILLOT C FRANCOIS E BEDENNE L
Citation: A. Degramont et al., RANDOMIZED TRIAL COMPARING MONTHLY LOW-DOSE LEUCOVORIN AND FLUOROURACIL BOLUS WITH BIMONTHLY HIGH-DOSE LEUCOVORIN AND FLUOROURACIL BOLUS PLUS CONTINUOUS-INFUSION FOR ADVANCED COLORECTAL-CANCER - A FRENCH INTERGROUP STUDY, Journal of clinical oncology, 15(2), 1997, pp. 808-815

Authors: VICHIERGUERRE S MORVAN F FULCRAND G RAYNER B
Citation: S. Vichierguerre et al., BOUNDARY BETWEEN DNA AND ENANTIO-DNA AS A MIMIC OF B-Z JUNCTION, Tetrahedron letters, 38(1), 1997, pp. 93-96

Authors: MIGNOT L MORVAN F
Citation: L. Mignot et F. Morvan, PREGNANCY AFTER BREAST-CARCINOMA, Contraception fertilite sexualite, 24(4), 1996, pp. 319-321

Authors: MORVAN F CHAIX C RAYNER B IMBACH JL
Citation: F. Morvan et al., EFFECT OF 5-METHYLCYTOSINE AND 5-BROMOURACIL IN ALPHA-OLIGODEOXYRIBONUCLEOTIDES ON THE STABILITY OF ALPHA-BETA-BETA TRIPLE HELICES, New journal of chemistry, 20(5), 1996, pp. 589-593

Authors: TOSQUELLAS G BARBER I MORVAN F RAYNER B IMBACH JL
Citation: G. Tosquellas et al., THE PROOLIGONUCLEOTIDE APPROACH .3. SYNTHESIS AND BIOREVERSIBILITY OFA CHIMERIC PHOSPHORODITHIOATE PROOLIGONUCLEOTIDE, Bioorganic & medicinal chemistry letters, 6(4), 1996, pp. 457-462

Authors: ALEKSEEV YI KRYNETSKAYA NF TASHLYTSKY VN ORETSKAYA TS DOLINNAYA NG MORVAN F RAYNER B MALVY C SHABAROVA ZA
Citation: Yi. Alekseev et al., INTERACTION OF ESCHERICHIA-COLI RIBONUCLEASE-H WITH HYBRID DUPLEXES CONTAINING 2'-DEOXYXYLOTHYMIDINE, 2'-DEOXY-2'FLUOROURIDINE OR ALPHA-THYMIDINE, Nucleosides & nucleotides, 15(9), 1996, pp. 1545-1558

Authors: DIERAS V EXTRA JM BELLISSANT E ESPIE M MORVAN F PIERGA JY MIGNOT L TRESCA P MARTY M
Citation: V. Dieras et al., EFFICACY AND TOLERANCE OF VINORELBINE AND FLUOROURACIL COMBINATION ASFIRST-LINE CHEMOTHERAPY OF ADVANCED BREAST-CANCER - RESULTS OF A PHASE-II STUDY USING A SEQUENTIAL GROUP METHOD, Journal of clinical oncology, 14(12), 1996, pp. 3097-3104

Authors: COOMBES RC BLISS JM WILS J MORVAN F ESPIE M AMADORI D GAMBROSIER P RICHARDS M AAPRO M VILLARGRIMALT A MCARDLE C PEREZLOPEZ FR VASSILOPOULOS P FERREIRA EP CHILVERS CED COOMBES G WOODS EM MARTY M
Citation: Rc. Coombes et al., ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL VERSUS FLUOROURACIL, EPIRUBICIN, AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN PREMENOPAUSAL WOMEN WITH AXILLARY NODE-POSITIVE OPERABLE BREAST-CANCER - RESULTS OF A RANDOMIZED TRIAL, Journal of clinical oncology, 14(1), 1996, pp. 35-45

Authors: DEROUET D MORVAN F BROSSE JC
Citation: D. Derouet et al., CHEMICAL MODIFICATION OF EPOXY-RESINS BY DIALKYL(OR ARYL) PHOSPHATES - EVALUATION OF FIRE BEHAVIOR AND THERMAL-STABILITY, Journal of applied polymer science, 62(11), 1996, pp. 1855-1868

Authors: MORVAN F SANGHVI YS PERBOST M VASSEUR JJ BELLON L
Citation: F. Morvan et al., OLIGONUCLEOTIDE MIMICS FOR ANTISENSE THERAPEUTICS - SOLUTION-PHASE AND AUTOMATED SOLID-SUPPORT SYNTHESIS OF MMI LINKED OLIGOMERS, Journal of the American Chemical Society, 118(1), 1996, pp. 255-256

Authors: LEYDIER C BELLON L BARASCUT JL MORVAN F RAYNER B IMBACH JL
Citation: C. Leydier et al., 4'-THIO-RNA - SYNTHESIS OF MIXED BASE 4'-THIO-OLIGORIBONUCLEOTIDES, NUCLEASE RESISTANCE, AND BASE-PAIRING PROPERTIES WITH COMPLEMENTARY SINGLE AND DOUBLE-STRAND, Antisense research and development, 5(3), 1995, pp. 167-174
Risultati: 1-25 | 26-40